BioNTech Comirnaty COVID-19 Vaccine from Japan
Comirnaty is Pfizer's mRNA COVID-19 vaccine in multi-dose vials for retail sale. Its spike protein induction classifies it as an immunological product under HTS 3002.15.00.
Duty Rate — Japan → United States
0%
Rate breakdown
9903.03.030%Articles the product of any country, as provided for in subdivision (aa)(ii) of U.S. note 2 to this subchapter
Import Tips
• Ultra-low temp vials (-80°C); dose extraction limits (6 doses/vial)
• Lipid nanoparticle composition declaration
• Post-thaw stability data prevents waste classification